Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children who have had normal physical and mental development for their age
- Both parents (and the child, if old enough) must agree to take part by signing a consent form
- The child must be covered by a social security (health insurance) scheme
- For the epilepsy groups: children who have been diagnosed with a specific type of age-related focal epilepsy (such as BECTS, ABPE, or ECSWS, based on recognised international criteria)
- For the epilepsy groups: children who are already being seen in hospital as part of their ongoing care
- For the epilepsy groups: children whose brain scans have come back normal
- For the comparison group: children who are in hospital for a condition that is not related to the brain or nervous system
Who may not be able to join:
- Children who have been diagnosed with a psychiatric condition (as defined by DSM-V criteria)
- Children who have a sensory problem (such as vision or hearing difficulties) that cannot be corrected
- Children who do not have a good enough command of the French language
- Children who are minors currently under legal guardianship or state care
- For the epilepsy groups: children who have a degenerative disease (a condition where the body or brain progressively deteriorates)
- For the epilepsy groups: children whose brain scans have shown abnormal results
- For the epilepsy groups: children who have an intellectual disability
- For the comparison group: children who have any neurological condition (a condition affecting the brain or nervous system)
- For the comparison group: children whose sleep brain activity test (EEG) has shown abnormal results
- For the comparison group: children who have an intellectual disability
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne DE SAINT MARTIN, MD, Hôpitaux Universitaires de Strasbourg
Phone: + 33 3.88.12.83.98
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
memory lapse rate at 24 hours in the severe group, the benign group and the control group. ("memory lapse rate": rate of non recalled words number, during the delayed recall phase of the test, related to the maximal number of words recalled
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.